18.05.2010
- Pros And Cons - European pharmaceutical manufacturing and API production has experienced a shift of a significant proportion of total production to Asia in recent years, driven...
25.03.2010
- Lonza has announced it will reduce its fixed costs in Basel and Visp by CHF 40 million over the next 18 months as part of a company-wide re-engineering initiative. The company said...
24.03.2010
- Swiss drugs industry supplier Lonza is in talks to buy over 5% stake in India's Aptuit Laurus in a deal valued at $77 million to $99 million, the Business Standard reported on...
26.01.2010
- The Chinese chemical and pharmaceutical industry has established itself as a significant player in the world. The number of chemical and pharmaceutical companies is continuously...
22.01.2010
- Following its announcement in October to adjust the organization to the more volatile market environment, Lonza has reported site closures. The company cites the economic pressures...
20.11.2009
- Israel's Teva Pharmaceutical Industries and Swiss drugs industry supplier Lonza Group won approval from the European Commission for a joint venture in the biosimilar industry. The...
